<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="40011" end="40022" sStart="-1" offset="0" sid="null" wn="3" wnkey="transfer%2:38:05::" text="Samples were resolved by SDS-PAGE (9% polyacrylamide) and electrophoretically &lt;b&gt;transferred&lt;/b&gt; to nitrocellulose filters (BioRad)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="25960" end="25968" sStart="null" offset="115" sid="r8.suggest.v.0323" wn="3" wnkey="suggest%2:32:02::" text="The second novel observation, that Syk kinase enzymatic activity was insufficient for signal transduction, suggests that multiple biochemical processes may be required for the Syk-dependent step of signal transduction." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="12873" end="12880" sStart="null" offset="188" sid="r8.suggest.v.0223" wn="3" wnkey="suggest%2:32:02::" text="These data indicate that the mutant Syk protein must be expressed together with the wildtype enzyme in cells to generate the dominant positive phenotype, and suggest that it's effect is indirect." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2172-3-16.anc" start="12677" end="12682" sStart="null" offset="0" sid="null" wn="4" wnkey="show%2:39:00::" text="Most significantly, a mixture of a lysate from unstimulated BCL 1 .3B3 cells harbouring wildtype Syk with a lysate from unstimulated DT40 expressing the K395A, 3F mutant Syk (see below), at 1:5, 1:1 and 5:1 ratios, &lt;b&gt;showed&lt;/b&gt; no activity in the immune complex kinase assay (data not &lt;b&gt;shown&lt;/b&gt;)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="4711" end="4716" sStart="null" offset="0" sid="null" wn="1" wnkey="serve%2:42:03::" text="In response to receptor activation, Syk becomes non-covalently associated with the BCR through tandem SH2 domains located in the amino terminal half of the protein [ 44 ] . Following engagement of the BCR, phosphorylation of specific tyrosine residues in immunoreceptor tyrosine-based activation motifs (ITAMs) found within the cytoplasmic tails of CD79a and CD79b provides docking sites for Syk localization [ 45 46 47 ] . The ability of phosphorylated ITAM peptides to selectively enhance Syk kinase activity in vitro suggests that recruitment of Syk to the receptor complex may &lt;b&gt;serve&lt;/b&gt; to activate the kinase, in part, through allosteric changes in the structure of the Syk protein [ 44 48 49 ] . Upon activation, Syk and the receptor complex become localized in detergent-resistant cholesterol-rich membrane microdomains (lipid rafts), resulting in the segregation of the BCR complex from other membrane components [ 50 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="29142" end="29147" sStart="null" offset="111" sid="r7.serve.v.0889" wn="1" wnkey="serve%2:42:03::" text="Multiple requirements for progression through this step in the signal transduction pathway may serve to integrate the cellular response to multiple environmental cues." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="4711" end="4716" sStart="null" offset="0" sid="null" wn="1" wnkey="serve%2:42:03::" text="In response to receptor activation, Syk becomes non-covalently associated with the BCR through tandem SH2 domains located in the amino terminal half of the protein [ 44 ] . Following engagement of the BCR, phosphorylation of specific tyrosine residues in immunoreceptor tyrosine-based activation motifs (ITAMs) found within the cytoplasmic tails of CD79a and CD79b provides docking sites for Syk localization [ 45 46 47 ] . The ability of phosphorylated ITAM peptides to selectively enhance Syk kinase activity in vitro suggests that recruitment of Syk to the receptor complex may &lt;b&gt;serve&lt;/b&gt; to activate the kinase, in part, through allosteric changes in the structure of the Syk protein [ 44 48 49 ] . Upon activation, Syk and the receptor complex become localized in detergent-resistant cholesterol-rich membrane microdomains (lipid rafts), resulting in the segregation of the BCR complex from other membrane components [ 50 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="4711" end="4716" sStart="null" offset="0" sid="null" wn="3" wnkey="serve%2:42:01::" text="In response to receptor activation, Syk becomes non-covalently associated with the BCR through tandem SH2 domains located in the amino terminal half of the protein [ 44 ] . Following engagement of the BCR, phosphorylation of specific tyrosine residues in immunoreceptor tyrosine-based activation motifs (ITAMs) found within the cytoplasmic tails of CD79a and CD79b provides docking sites for Syk localization [ 45 46 47 ] . The ability of phosphorylated ITAM peptides to selectively enhance Syk kinase activity in vitro suggests that recruitment of Syk to the receptor complex may &lt;b&gt;serve&lt;/b&gt; to activate the kinase, in part, through allosteric changes in the structure of the Syk protein [ 44 48 49 ] . Upon activation, Syk and the receptor complex become localized in detergent-resistant cholesterol-rich membrane microdomains (lipid rafts), resulting in the segregation of the BCR complex from other membrane components [ 50 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="4711" end="4716" sStart="null" offset="0" sid="null" wn="1" wnkey="serve%2:42:03::" text="In response to receptor activation, Syk becomes non-covalently associated with the BCR through tandem SH2 domains located in the amino terminal half of the protein [ 44 ] . Following engagement of the BCR, phosphorylation of specific tyrosine residues in immunoreceptor tyrosine-based activation motifs (ITAMs) found within the cytoplasmic tails of CD79a and CD79b provides docking sites for Syk localization [ 45 46 47 ] . The ability of phosphorylated ITAM peptides to selectively enhance Syk kinase activity in vitro suggests that recruitment of Syk to the receptor complex may &lt;b&gt;serve&lt;/b&gt; to activate the kinase, in part, through allosteric changes in the structure of the Syk protein [ 44 48 49 ] . Upon activation, Syk and the receptor complex become localized in detergent-resistant cholesterol-rich membrane microdomains (lipid rafts), resulting in the segregation of the BCR complex from other membrane components [ 50 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="8835" end="8840" sStart="null" offset="0" sid="null" wn="2" wnkey="rapid%5:00:02:fast:01" text="The &lt;b&gt;rapid&lt;/b&gt; induction of tyrosine phosphorylation and its subsequent reduction paralleled the kinetics of Syk kinase activity (Figure 2B)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="13488" end="13493" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Incubation with anti-IgM induced a &lt;b&gt;rapid&lt;/b&gt; increase and delayed reduction in Syk activity with kinetics similar to that of control clones." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="22324" end="22329" sStart="null" offset="0" sid="null" wn="2" wnkey="rapid%5:00:02:fast:01" text="Previous studies have identified apoptosis and cell cycle arrest as mechanisms of BCR-induced growth arrest in BCL 1 .3B3 cells [ 19 ] . The studies presented here have demonstrated that stimulation of the BCR resulted in the &lt;b&gt;rapid&lt;/b&gt; and transient activation of the non-receptor tyrosine kinase, Syk." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="8835" end="8840" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="The &lt;b&gt;rapid&lt;/b&gt; induction of tyrosine phosphorylation and its subsequent reduction paralleled the kinetics of Syk kinase activity (Figure 2B)." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="13488" end="13493" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Incubation with anti-IgM induced a &lt;b&gt;rapid&lt;/b&gt; increase and delayed reduction in Syk activity with kinetics similar to that of control clones." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="13488" end="13493" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Incubation with anti-IgM induced a &lt;b&gt;rapid&lt;/b&gt; increase and delayed reduction in Syk activity with kinetics similar to that of control clones." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="13488" end="13493" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Incubation with anti-IgM induced a &lt;b&gt;rapid&lt;/b&gt; increase and delayed reduction in Syk activity with kinetics similar to that of control clones." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="13488" end="13493" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Incubation with anti-IgM induced a &lt;b&gt;rapid&lt;/b&gt; increase and delayed reduction in Syk activity with kinetics similar to that of control clones." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="13488" end="13493" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Incubation with anti-IgM induced a &lt;b&gt;rapid&lt;/b&gt; increase and delayed reduction in Syk activity with kinetics similar to that of control clones." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="13488" end="13493" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Incubation with anti-IgM induced a &lt;b&gt;rapid&lt;/b&gt; increase and delayed reduction in Syk activity with kinetics similar to that of control clones." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="13488" end="13493" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Incubation with anti-IgM induced a &lt;b&gt;rapid&lt;/b&gt; increase and delayed reduction in Syk activity with kinetics similar to that of control clones." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="22324" end="22329" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Previous studies have identified apoptosis and cell cycle arrest as mechanisms of BCR-induced growth arrest in BCL 1 .3B3 cells [ 19 ] . The studies presented here have demonstrated that stimulation of the BCR resulted in the &lt;b&gt;rapid&lt;/b&gt; and transient activation of the non-receptor tyrosine kinase, Syk." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="13488" end="13493" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="Incubation with anti-IgM induced a &lt;b&gt;rapid&lt;/b&gt; increase and delayed reduction in Syk activity with kinetics similar to that of control clones." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="251" end="257" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="The B cell antigen receptor (BCR) is a multi-subunit complex that acts as a key sensor regulating the response of lymphocytes to their environment (reviewed in [ 1 2 3 4 5 6 7 ] ). In &lt;b&gt;mature&lt;/b&gt; B cells, activation through the BCR stimulates cellular proliferation and differentiation." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="251" end="257" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="The B cell antigen receptor (BCR) is a multi-subunit complex that acts as a key sensor regulating the response of lymphocytes to their environment (reviewed in [ 1 2 3 4 5 6 7 ] ). In &lt;b&gt;mature&lt;/b&gt; B cells, activation through the BCR stimulates cellular proliferation and differentiation." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="25471" end="25477" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="BCR-induced interaction between Cbl and Syk increases the susceptibility of Syk to proteolysis [ 55 ] , possibly through enhancement of ubiquitination [ 56 ] . Expression of a dominant-negative SHP-1 phosphatase in the &lt;b&gt;mature&lt;/b&gt; murine B cell line K46 resulted in an increase in BCR-induced Syk kinase activity as measured by C3b phosphorylation in an ICKA and enhanced BCR-induced Ca 2+fluxes [ 57 ] . It remains to be determined if interference with any of these known regulatory proteins is responsible for the dominant-positive effect." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="1870" end="1876" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="Although much is known about the biochemical changes occurring in response to BCR-mediated activation, the differences in the signal transduction pathways that give rise to the different cellular responses following activation of the same receptor in immature versus &lt;b&gt;mature&lt;/b&gt; cells have yet to be elucidated completely (discussed in detail in refs." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="251" end="257" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="The B cell antigen receptor (BCR) is a multi-subunit complex that acts as a key sensor regulating the response of lymphocytes to their environment (reviewed in [ 1 2 3 4 5 6 7 ] ). In &lt;b&gt;mature&lt;/b&gt; B cells, activation through the BCR stimulates cellular proliferation and differentiation." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="25471" end="25477" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="BCR-induced interaction between Cbl and Syk increases the susceptibility of Syk to proteolysis [ 55 ] , possibly through enhancement of ubiquitination [ 56 ] . Expression of a dominant-negative SHP-1 phosphatase in the &lt;b&gt;mature&lt;/b&gt; murine B cell line K46 resulted in an increase in BCR-induced Syk kinase activity as measured by C3b phosphorylation in an ICKA and enhanced BCR-induced Ca 2+fluxes [ 57 ] . It remains to be determined if interference with any of these known regulatory proteins is responsible for the dominant-positive effect." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="1870" end="1876" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="Although much is known about the biochemical changes occurring in response to BCR-mediated activation, the differences in the signal transduction pathways that give rise to the different cellular responses following activation of the same receptor in immature versus &lt;b&gt;mature&lt;/b&gt; cells have yet to be elucidated completely (discussed in detail in refs." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="14249" end="14255" sStart="null" offset="107" sid="r9.level.n.0655" wn="1" wnkey="level%1:07:00::" text="Syk from unstimulated BCL 1 .3B3 and vector control clones had undetectable levels of phospho-tyrosine (lanes 1,3,4, and 6, upper panel)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="8080" end="8086" sStart="null" offset="127" sid="r9.level.n.0676" wn="2" wnkey="level%1:26:01::" text="Maximal Syk activation occurred within 1 min of receptor engagement (lane 3) and decreased to intermediate levels at times thereafter (lanes 4 and 5)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="6604" end="6608" sStart="null" offset="132" sid="null" wn="2147483645" wnkey="null" text="Using flow cytometry to measure membrane permeability and DNA content of cells, BCR stimulation resulted in a 5-fold increase (6." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="6604" end="6608" sStart="null" offset="132" sid="r9.fold.v.0021" wn="2147483646" wnkey="null" text="Using flow cytometry to measure membrane permeability and DNA content of cells, BCR stimulation resulted in a 5-fold increase (6." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="6604" end="6608" sStart="null" offset="132" sid="null" wn="2147483645" wnkey="null" text="Using flow cytometry to measure membrane permeability and DNA content of cells, BCR stimulation resulted in a 5-fold increase (6." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="6604" end="6608" sStart="null" offset="132" sid="null" wn="2147483645" wnkey="null" text="Using flow cytometry to measure membrane permeability and DNA content of cells, BCR stimulation resulted in a 5-fold increase (6." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="6604" end="6608" sStart="null" offset="132" sid="r9.fold.v.0021" wn="2147483646" wnkey="null" text="Using flow cytometry to measure membrane permeability and DNA content of cells, BCR stimulation resulted in a 5-fold increase (6." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="6604" end="6608" sStart="null" offset="132" sid="null" wn="2147483645" wnkey="null" text="Using flow cytometry to measure membrane permeability and DNA content of cells, BCR stimulation resulted in a 5-fold increase (6." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="6604" end="6608" sStart="null" offset="132" sid="r9.fold.v.0021" wn="2147483645" wnkey="null" text="Using flow cytometry to measure membrane permeability and DNA content of cells, BCR stimulation resulted in a 5-fold increase (6." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="6604" end="6608" sStart="null" offset="132" sid="null" wn="2147483645" wnkey="null" text="Using flow cytometry to measure membrane permeability and DNA content of cells, BCR stimulation resulted in a 5-fold increase (6." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="6604" end="6608" sStart="null" offset="132" sid="null" wn="2147483645" wnkey="null" text="Using flow cytometry to measure membrane permeability and DNA content of cells, BCR stimulation resulted in a 5-fold increase (6." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="6604" end="6608" sStart="null" offset="132" sid="r9.fold.v.0021" wn="" wnkey="null" text="Using flow cytometry to measure membrane permeability and DNA content of cells, BCR stimulation resulted in a 5-fold increase (6." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="5767" end="5772" sStart="null" offset="121" sid="r10.find.v.0766" wn="2" wnkey="find%2:39:02::" text="However, although these cells carry a highly active Syk kinase, no evidence for downstream signaling was found." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="33003" end="33012" sStart="null" offset="124" sid="r8.1.different.j.0197" wn="4" wnkey="different%5:00:01:other:00" text="Immunoblotting for the detection of Syk protein utilized a rabbit anti-Syk antibody generated against a different epitope (SC-1077, Santa Cruz Biotechnology)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="10071" end="10082" sStart="null" offset="94" sid="r11.combination.n.0394" wn="1" wnkey="combination%1:14:00::" text="Based on the effects of similar mutations in other kinases it was expected that the combination of these replacements in (K395A/3F)Syk might produce a dominant negative effect." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="14823" end="14829" sStart="null" offset="0" sid="null" wn="1" wnkey="become%2:30:00::" text="Syk from all clones analyzed &lt;b&gt;became&lt;/b&gt; tyrosine phosphorylated after BCR stimulation (lanes 2, 5, 8 and 11)." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="3277" end="3284" sStart="null" offset="146" sid="r9.appear.v.0954" wn="1" wnkey="appear%2:39:00::" text="In contrast, BCR-mediated activation of Lyn kinase was largely maintained [ 37 38 ] . The Syk-dependent signaling pathway appears to be facilitated by the adaptor molecule BLNK (also known as SLP-65 and BASH) [ 39 40 41 ] . Syk can induce the phosphorylation of BLNK in co-transfection experiments [ 42 ] , which may be important for the recruitment of other Syk substrates like PLC?2 through a scaffolding function [ 42 ] . BLNK function is necessary for signal transduction since no Ca 2+flux or PLC?2 phosphorylation is observed in response to BCR engagement in BLNK-deficient DT40 cells [ 43 ] ." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2172-3-16.anc" start="7070" end="7075" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="BCR-mediated tyrosine kinase activation is thought to be involved in the signal transduction cascades that give rise to these changes in cell growth and viability [ 19 ] . To determine if BCR engagement under these conditions leads to Syk kinase activation, increasing amounts of anti-IgM were &lt;b&gt;added&lt;/b&gt; to cultured BCL 1 .3B3 cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="26731" end="26738" sStart="null" offset="153" sid="r11.absence.n.0290" wn="1" wnkey="absence%1:26:00::" text="This is not surprising since the ITAMs in CD79, which are proposed to be docking sites for Syk, are unlikely to be phosphorylated in the absence of BCR stimulation since phosphorylation of these residues likely requires activation of Src family tyrosine kinases expressed in B cells." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="28796" end="28803" sStart="null" offset="4" sid="r11.absence.n.0858" wn="1" wnkey="absence%1:26:00::" text="The absence of signaling in the presence of constitutive enzymatic activity described for Syk in different systems implies that execution of the Syk-dependent step in this signaling cascade is a multi-step process." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="29779" end="29786" sStart="null" offset="153" sid="r11.absence.n.0771" wn="1" wnkey="absence%1:26:00::" text="In summary, here we describe the use of a mutant Syk construct to produce a dominant-positive effect on endogenous Syk activation in the absence of BCR engagement." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="25066" end="25073" sStart="null" offset="175" sid="r11.absence.n.0729" wn="1" wnkey="absence%1:26:00::" text="By sequestering this negative regulator, expression of the mutant Syk molecules gives rise to the activation of the endogenous wildtype protein in the absence of specific stimulation, leading to a constitutively active Syk phenotype." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="28250" end="28257" sStart="null" offset="19" sid="r11.absence.n.0618" wn="1" wnkey="absence%1:26:00::" text="Alternatively, the absence of signal transduction in the presence of Syk activity may be related to its ability to interact with its downstream targets." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="5343" end="5350" sStart="null" offset="231" sid="r11.absence.n.0468" wn="1" wnkey="absence%1:26:00::" text="In this report, we describe the use of a mutant form of Syk that leads to the constitutive activation of the endogenous wildtype Syk kinase when introduced into B cells - a dominant positive effect - in the absence of detectable tyrosine phosphorylation." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2172-3-16.anc" start="27155" end="27162" sStart="null" offset="253" sid="r11.absence.n.0258" wn="1" wnkey="absence%1:26:00::" text="Therefore, despite constitutive Syk kinase activity, the ITAMs in the dominant-positive-expressing cells remain hypophosphorylated because kinases that are upstream of Syk and/or are Syk independent are not active in the absence of BCR crosslinking." />
  </sentences>
</list>